Related Experiment Video
Updated: May 5, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Activation of farnesoid X receptor induces RECK expression in mouse liver
Xiaomin Peng1, Weibin Wu2, Bo Zhu1
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Abstract:
Farnesoid X receptor (FXR) belongs to the ligand-activated nuclear receptor superfamily, and functions as a transcription factor regulating the transcription of numerous genes involved in bile acid homeostasis, lipoprotein and glucose metabolism. In the present study, we identified RECK, a membrane-anchored inhibitor of matrix metalloproteinases, as a novel target gene of FXR in mouse liver. We found that FXR agonist substantially augmented hepatic RECK mRNA and protein expression in vivo and in vitro. FXR regulated the transcription of RECK through directly binding to FXR response element located within intron 1 of the mouse RECK gene. Moreover, FXR agonist reversed the down-regulation of RECK in the livers from mice fed a methionine and choline deficient diet. In summary, our data suggest that RECK is a novel transcriptional target of FXR in mouse liver, and provide clues to better understanding the function of FXR in liver.
Insights
Farnesoid X receptor (FXR) regulates RECK gene expression in the liver. This nuclear receptor directly binds to the RECK gene, influencing bile acid and metabolic homeostasis.
Area of Science:
- Molecular Biology
- Hepatology
- Nuclear Receptor Signaling
Background:
- Farnesoid X receptor (FXR) is a nuclear receptor crucial for regulating bile acid, lipoprotein, and glucose metabolism.
- FXR acts as a transcription factor for various genes involved in hepatic homeostasis.
Purpose of the Study:
- To identify novel target genes of FXR in the mouse liver.
- To investigate the role of FXR in regulating RECK gene expression and its potential involvement in liver metabolic processes.
Main Methods:
- In vivo and in vitro experiments using FXR agonists.
- Analysis of RECK mRNA and protein expression.
- Identification of FXR binding sites on the RECK gene promoter region.
- Studies using a methionine and choline-deficient diet model.
Main Results:
- RECK was identified as a novel target gene of FXR in mouse liver.
- FXR agonists significantly increased hepatic RECK mRNA and protein levels.
- FXR directly binds to a response element in intron 1 of the mouse RECK gene.
- FXR activation reversed RECK downregulation in mice fed a methionine and choline-deficient diet.
Conclusions:
- RECK is a novel transcriptional target of FXR in the mouse liver.
- FXR plays a role in regulating RECK expression, contributing to liver metabolic regulation.
- These findings provide insights into the broader functions of FXR in hepatic physiology.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of the Unfolded Protein Response
Co-activators and Co-repressors
Cell Specific Gene Expression
MAPK Signaling Cascades